Insider and congress filings

AbbVie Inc. (ABBV)

NYSE · Healthcare · 367 insider filings · 201 congress trades · last filed 24 days agoS&P 500

4
Open-market insider filings shown
2d
Median delay on the insider filings
within the two business day rule
0/4
Purchases and sales in the filings shown

About AbbVie Inc.

from the company's filings and listing
Exchange
NYSE
Sector
Healthcare
Industry
Drug Manufacturers - General
Chief executive
Robert A. Michael
Employees
57,000
Listed since
Jan 2, 2013
Market value
$443.4B
Price to earnings
70.7
Earnings per share
$3.57
Dividend yield
2.72%

www.abbvie.com

Earnings

6 reported quarters · next on Oct 30, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Jul 31, 2026$3.65$3.61$17.0B$16.8BEPS in lineRevenue in line
Q1 FY2026reported Apr 29, 2026$2.65$2.59$15.0B$14.7BEPS beatRevenue beat
Feb 4, 2026$2.71$2.65$16.6B$16.4BEPS beatRevenue in line
Q3 FY2025reported Oct 31, 2025$1.86$1.77$15.8B$15.6BEPS beatRevenue in line
Q2 FY2025reported Jul 31, 2025$2.97$2.88$15.4B$15.0BEPS beatRevenue beat
Apr 25, 2025$2.46$2.38$13.3B$12.9BEPS beatRevenue beat

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for 2025 · proxy filed Mar 23, 2026
ExecutiveSalaryStock awardsOtherTotal
Robert A. MichaelChairman of the Board and Chief Executive Officer$1.7M$13.3M$17.6M$32.5M
Jeffrey R. StewartExecutive Vice President, Chief Commercial Officer$1.3M$5.4M$8.7M$15.4M
Scott T. ReentsExecutive Vice President, Chief Financial Officer$1.1M$4.4M$6.9M$12.4M
Azita Saleki-GerhardtExecutive Vice President, Chief Operations Officer$1.1M$4.0M$5.8M$10.8M
Roopal B. ThakkarExecutive Vice President, Research & Development and C$1.1M$4.0M$4.8M$9.9M

The summary compensation table from the 2025 proxy statement, current executives only. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesChangeOf company
Blackrock, Inc.$37.6B149,488,412-0.8%8.44%
Vanguard Capital Management LLC$29.0B115,396,098+0.4%6.52%
State Street Corp$20.8B82,596,748+1.7%4.66%
Vanguard Portfolio Management LLC$12.2B48,477,996-2.1%2.74%
Jpmorgan Chase & Co$12.2B47,862,796-15.6%2.70%
Geode Capital Management, LLC$11.8B46,998,433+0.6%2.65%
Morgan Stanley$9.8B38,901,001+2.3%2.20%
Capital Research Global Investors$7.6B30,101,551-3.7%1.70%
Norges Bank$6.4B25,554,538+100.0%1.44%
Bank Of America Corp$5.3B21,237,764-11.3%1.20%
FMR LLC$5.2B20,773,786-4.5%1.17%
Northern Trust Corp$5.2B20,558,447-3.1%1.16%

A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.

Know the moment the next ABBV filing lands.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Open-market insider trades

4 filings of 367 on record
InsiderActionSharesPriceValueTrade dateDelay
Nicholas DonoghoeEVP, Chief BUS/Strat OfficerSold32,710$250.00$8.2MAug 14, 20264d
David Ryan PurdueSVP, ControllerSold5,230$233.56$1.2MMar 4, 20262d
Perry C. SiatisEVP, GC and SecretarySold · 3 lines18,668$234.39$4.4MMar 2, 20261d
Perry C. SiatisEVP, GC and SecretarySold22,381$230.00$5.1MFeb 25, 20262d

One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.

Congress trades in ABBV

20 disclosures of 201 on record · median 28d of the 45 allowed
MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Alan ArmstrongSelfFiled lateStockPurchase$15,001 - $50,000+19.8%S&P +20.2% · vs S&P 500 -0.4%Mar 27, 2026Jul 21, 2026116d
Ro KhannaStockPurchase$1,001 - $15,000+16.5%S&P +0.4% · vs S&P 500 +16.1%Jun 2, 2026Jul 6, 202634d
Ro KhannaStockPurchase$15,001 - $50,000+21.5%S&P +5.8% · vs S&P 500 +15.7%May 1, 2026Jun 9, 202639d
Ro KhannaStockPurchase$15,001 - $50,000+19.3%S&P +3.2% · vs S&P 500 +16.1%May 15, 2026Jun 9, 202625d
Josh GottheimerJointStockSale$1,001 - $15,000+21.7%S&P +5.4% · vs S&P 500 +16.4%May 5, 2026Jun 3, 202629d
Ro KhannaStockSale$15,001 - $50,000+21.5%S&P +11.1% · vs S&P 500 +10.4%Apr 13, 2026May 11, 202628d
Ro KhannaStockSale$15,001 - $50,000+17.7%S&P +20.7% · vs S&P 500 -2.9%Mar 30, 2026Apr 7, 20268d
Ro KhannaStockPurchase$15,001 - $50,000+14.6%S&P +12.5% · vs S&P 500 +2.1%Feb 5, 2026Mar 9, 202632d
Ro KhannaStockPurchase$1,001 - $15,000+14.4%S&P +10.6% · vs S&P 500 +3.9%Jan 23, 2026Feb 6, 202614d
Ro KhannaStockSale$15,001 - $50,000+13.8%S&P +9.8% · vs S&P 500 +4.0%Jan 29, 2026Feb 6, 20268d
Julie JohnsonJointStockSale$1,001 - $15,000+12.6%S&P +12.7% · vs S&P 500 -0.1%Dec 18, 2025Jan 15, 202628d
Julia LetlowFiled lateStockPurchase$1,001 - $15,000+32.9%S&P +32.1% · vs S&P 500 +0.7%Oct 23, 2024Jan 13, 2026447d
Julia LetlowFiled lateStockSale$1,001 - $15,000+46.6%S&P +25.6% · vs S&P 500 +21.0%Jan 24, 2025Jan 13, 2026354d
Julia LetlowFiled lateStockPurchase$1,001 - $15,000+29.8%S&P +38.6% · vs S&P 500 -8.8%Apr 28, 2025Jan 13, 2026260d
Julia LetlowStockSale$1,001 - $15,000+12.5%S&P +11.5% · vs S&P 500 +1.0%Dec 8, 2025Jan 13, 202636d
Julie JohnsonJointStockSale$1,001 - $15,000+8.0%S&P +13.4% · vs S&P 500 -5.4%Nov 13, 2025Dec 11, 202528d
Lisa C. McClainSpouseStockSale$1,001 - $15,000+15.1%S&P +11.8% · vs S&P 500 +3.3%Oct 31, 2025Nov 21, 202521d
Lisa C. McClainSpouseStockSale$1,001 - $15,000+9.4%S&P +12.3% · vs S&P 500 -2.9%Oct 30, 2025Nov 21, 202522d
Lisa C. McClainSpouseStockPurchase$1,001 - $15,000+9.4%S&P +12.3% · vs S&P 500 -2.9%Oct 30, 2025Nov 21, 202522d
John BoozmanJointStockSale (Partial)$1,001 - $15,000+19.1%S&P +18.2% · vs S&P 500 +1.0%Aug 22, 2025Sep 12, 202521d

Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.

Members of Congress reporting a position

22 members · estimate, as of Sep 10, 2026

22 members report a position (estimated). The largest estimated position is in the $500,001 - $1,000,000 band.

MemberParty, chamberEstimated positionShare of their portfolio
John W. HickenlooperDemocrat · Senate$500,001 - $1,000,0002.2%
J. French HillRepublican · House$250,001 - $500,0001.7%
Rick W. AllenRepublican · House$100,001 - $250,0003.1%
Gary C. PetersDemocrat · Senate$100,001 - $250,0002.8%
Carol D. MillerRepublican · House$50,001 - $100,0003.5%
Gilbert Ray Cisneros, Jr.Democrat · House$50,001 - $100,0000.2%
Kelly MorrisonDemocrat · House$50,001 - $100,0000.6%
Robert BresnahanRepublican · House$50,001 - $100,0000.6%
Randy FineRepublican · House$50,001 - $100,0003.8%
Jared MoskowitzDemocrat · House$50,001 - $100,0001.2%
Tommy TubervilleRepublican · Senate$15,001 - $50,0001.4%
Marjorie Taylor GreeneRepublican · House$15,001 - $50,0000.9%
Pete SessionsRepublican · House$15,001 - $50,0000.9%
Virginia FoxxRepublican · House$15,001 - $50,0002.4%
Cliff BentzRepublican · House$1,001 - $15,0000.6%
Daniel MeuserRepublican · House$1,001 - $15,0000.4%
Dwight EvansDemocrat · House$1,001 - $15,0005.7%
John McGuireRepublican · House$1,001 - $15,0001.9%
Julie JohnsonDemocrat · House$1,001 - $15,0000.1%
Michael A. RulliRepublican · House$1,001 - $15,0000.9%
Robert B. AderholtRepublican · House$1,001 - $15,0001.1%
Robert J. WittmanRepublican · House$1,001 - $15,0000.9%

Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.

Awards, option exercises and gifts (20)
InsiderEventSharesDate
Nicholas DonoghoeEVP, Chief BUS/Strat OfficerOption exercise32,710Aug 14, 2026
Edward J. RappDirectorStock award134Jun 30, 2026
Susan E. QuagginDirectorStock award62Jun 30, 2026
Melody B. MeyerDirectorStock award1,118May 8, 2026
Susan E. QuagginDirectorStock award1,118May 8, 2026
Brett J. HartDirectorStock award1,118May 8, 2026
Thomas C. FreymanDirectorStock award1,118May 8, 2026
Frederick H. WaddellDirectorStock award1,118May 8, 2026
William H.L. BurnsideDirectorStock award1,118May 8, 2026
Roxanne S. AustinDirectorStock award1,118May 8, 2026
Jennifer L. DavisDirectorStock award1,118May 8, 2026
Rebecca B. RobertsDirectorStock award1,118May 8, 2026
Edward J. RappDirectorStock award1,118May 8, 2026
Thomas J. FalkDirectorStock award1,118May 8, 2026
Robert J. AlpernDirectorStock award35Mar 31, 2026
Susan E. QuagginDirectorStock award71Mar 31, 2026
Edward J. RappDirectorStock award155Mar 31, 2026
David Ryan PurdueSVP, ControllerTax withholding2,108Feb 27, 2026
Demetris D. CrumEVP, Chief HR OfficerTax withholding1,594Feb 27, 2026
Jeffrey Ryan StewartEVP, Chief Commercial OfficerTax withholding23,812Feb 27, 2026

Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.

Questions

Are insiders buying or selling ABBV?

Across the 4 most recent open-market filings shown here, 0 were purchases and 4 were sales.

Which members of Congress have traded ABBV?

Alan Armstrong, Ro Khanna, Josh Gottheimer, Julie Johnson, Julia Letlow, Lisa C. McClain and others disclosed ABBV transactions in the filings shown here.

Which members of Congress hold ABBV?

22 members of Congress report a position in ABBV in the estimate we hold as of Sep 10, 2026. The three largest estimated positions belong to John W. Hickenlooper, J. French Hill and Rick W. Allen. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.

Is ABBV in the S&P 500 or the Nasdaq 100?

AbbVie Inc. is a current member of the S&P 500, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.

How quickly are ABBV trades disclosed?

Insider filings on this page reached the public a median of 2 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 28 days, against the 45 the STOCK Act allows.

How to read a Form 4

A DECISION THE INSIDER MADE

POpen-market purchase. Bought with their own money at the market price.
SOpen-market sale. Sold on the market. A sale marked scheduled was set up in advance under a Rule 10b5-1 plan, often months before.

COMPENSATION PLUMBING

AStock award. Granted as pay, not bought.
MOption exercise. Converting options already held into shares.
FTax withholding. Shares handed back to the company to pay the tax on a grant.
GGift. Given away, with no money changing hands.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Sep 10, 2026.

Related companies

traded by the same members

See every company we track